In vitro pathological model of osteopenia to test orthopaedic biomaterials

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 28, Issue 2, 2000, Pages 181-192

  Torricelli, Paola ^a   Fini, Milena ^a   Rocca, Michele ^a   Giavaresi, Gianluca ^a   Giardino, Roberto ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; OSTEOCALCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; IMPLANT; IN VITRO STUDY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; RAT;

ANIMALIA;

EID: 0034052156     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731190009118580     Document Type: Article

References (32)

1. Sennerby, L., Thomsen, P., Tissue response to titanium implants in experimental antigen-induced arthritis. Biomaterials, 14(6): 413-422 (1993).
2. Soballe, K., Hansen, E.S., Brockstedt-Rasmussen, H. et al., Fixation of titanium and hydroxyapatite coated implants in arthritic osteopenic bone. J. Arthroplasty, 6(4): 307-316 (1991).
3. Muzzarelli, R.A.A., Biagini, G., Mattioli Belmonte, M. et al., Osteoinduction by Chitosan-complexed BMP : morpho-structural responses in an osteoporotic model. J Bioactive and Compatible Polymers, 12: 321-329 (1997).
4. Hayashi, K., Uenoyama, K., Matsuguchi, N., Nakagawa, S., Sugioka, Y., The affinity of bone to Hydroxyapatite and alumina in experimentally induced osteoporosis. J. Arthroplasty, 4(3): 256-262 (1989).
5. Hayashi, K., Uenoyama, K., Mashima, T., Sugioka, Y., Remodeling of bone around hydroxyapatite and titanium in experimental osteoporosis. Biomaterials, 15(1): 11-16 (1994).
6. Martin, R.B., Paul, H.A., Bargar, W.L., Dannucci, G.A., Sharkey, N.A., Effects of estrogen deficiency on the growth of tissue into porous titanium implants. J. Bone Joint Surg. (Am.), 70(4): 540-547 (1988).
7. Mori, H., Manabe, M., Kurachi, Y., Nagumo, M., Osteointegration of dental implants in rabbit bone with low mineral density. J. Oral Maxillofac. Surg., 55(4): 351-361 (1997).
8. Fini, M., Nicoli, N., Gandolfi, M.G. et al., Biomaterials for orthopaedic surgery in osteoporotic bone : a comparative study in osteopenic rats. Int. J. Artif. Organs, 20(5): 291-297 (1997).
9. International Standard ISO 10993-2:1992 (E). Biological evaluation of medical devices-Part 2 : Animal welfare requirements.
10. Halstead, L.R., Scott, M.J., Rifas, L., Avioli, L.V., Characterization of osteoblast-like cells from normal adult rat femoral trabecular bone. Calcif Tissue Int, 50: 93-95 (1992).
11. Modrowski, D., Marie, P.J., Cells isolated from the endosteal bone surface of adult rats express differentiated osteoblastic characteristics in vitro. Cell Tissue Res, 271(3): 499-505 (1993).
12. Kawai, N., Niwa, S., Sato, M., Sato, Y., Suwa, Y., Ichihara, I., Bone formation by cells from femurs cultured among three-dimensionally arranged hydroxyapatite granules. J Biomed Mater Res, 37(1): 1-8 (1997).
13. Morrison, C., Macnair, R., MacDonald, C., Wykman, A., Goldie, I., Grant, M.H., In vitro biocompatibility testing of polymers for orthopaedic implants using cultured fibroblasts and osteoblasts. Biomaterials, 16(13): 987-992 (1995).
14. Massas, R., Pitaru, S., Weinreb, M.M., The effects of titanium and hydroxyapatite on osteoblastic expression and proliferation in rat parietal bone cultures. J Dent Res, 72(6): 1005-1008 (1993).
15. Mattioli Belmonte, M., De Benedittis, A., Muzzarelli, R.A.A. et al., Bioactivity modulation of bioactive materials in view of their application in osteoporotic patients. In Press in J Mat Sci Mat Met (1998).
16. Giavaresi, G., Fini, M., Gnudi, S. et al, Effect of pulsed electromagnetic fields on ovariectomised rats. In Press in Electro Magnetobiol.(1998).
17. Begley, C.T., Doherty, M.J., Hankley, D.P., Wilson, D.J., The culture of human osteoblast upon bone graft substitutes. Bone, 14(4): 661-666 (1993).
18. Cheung, H.S., Haak, M.H., Growth of osteoblasts on porous calcium phosphate ceramic: an in vitro model for biocompatibility study. Biomaterials, 10(1): 63-67 (1989).
19. Puleo, D.A., Holleran, L.A., Doremus, R.H., Bizios, R., Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res, 25(6): 711-723 (1991).
20. Hunter, A., Archer, C.W., Walker, P.S., Blunn, G.W., Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use. Biomaterials, 16(4): 287-295 (1995).
21. Alliot-Licht, B., Gregoire, M., Orly, I., Menanteau, J., Cellular activity of osteoblasts in the presence of hydroxiapatite: an in vitro experiment. Biomaterials, 12(8): 752-756 (1991).
22. Groessner-Schreiber, B., Tuan, R.S., Enhanced extracellular matrix production and mineralization by osteoblasts cultured on titanium surfaces in vitro. J Cell Sci, 101(1): 209-217 (1992).
23. Vrouwenvelder, W.C., Groot, C.G., de Groot, K., Histological and biochemical evaluation of osteoblast cultured on bioactive glass, hydroxyapatite, titanium alloy, and stainless steel. J Biomed Mater Res, 27(4): 465-475 (1993).
24. Vrouwenvelder, W.C., Groot, C.G., de Groot, K., Behavior of fetal rat osteoblasts cultured in vitro on bioactive glass and nonreactive glasses. Biomaterials, 13(6): 382-392 (1992).
25. Hilal, G., Martel-Pelletier, J., Pelletier, J.P., Ranger, P., Lajeunesse, D., Osteoblast-like cells from subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum, 41(5):891-899 (1998).
26. Lajeunesse, D., Busque, L., Menard, P., Brunette, M.G., Bonny, Y., Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant. J Clin Invest, 98(8): 1835-1842 (1996).
27. Morike, M., Shulz, M., Brenner, R.E., Bushart, G.B., Teller, W.M., Vetter, U., In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta. J Cell Physiol, 157(3):439-444 (1993).
28. Marie, P.J., Sabbagh, A., de Vernejoul, M.C., Lomri, A., Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab, 69(2):272-279 (1989).
29. Lomri, A., Marie, P.J., Bone cells responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. J Bone Miner Res, 5(11):1149-1155 (1990).
30. Wong, M.M., Rao, L.G., Ly, H. et al., In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int, 4:21-31 (1994).
31. Sasse, T., Becker, P., Dorfling, P., Schuhr, T., Brock, J., TGF beta-1 mRNA expression and proliferation of human osteoblastic cells in nonosteoporotic and osteoporotic women under influence of TGF beta-1 and IGF-I. Calcif Tissue Int, 62(2):140-147 (1998).
32. Byers, R.J., Denton, J., Hoyland, J.A., Freemont AJ. Differential patterns of osteoblast dysfunction in trabecular bone in patients with established osteoporosis. J Clin Pathol, 50(9):760-764 (1997).